Works matching IS 10837159 AND DT 2023 AND VI 28 AND IP 6
Results: 29
Response to Pralsetinib in Multi-Drug-Resistant Breast Cancer With CCDC6-RET Mutation.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e416, doi. 10.1093/oncolo/oyad115
- By:
- Publication type:
- Article
Clinical Outcomes of Afatinib Versus Osimertinib in Patients With Non-Small Cell Lung Cancer With Uncommon EGFR Mutations: A Pooled Analysis.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e397, doi. 10.1093/oncolo/oyad111
- By:
- Publication type:
- Article
Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular Carcinoma.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e369, doi. 10.1093/oncolo/oyad083
- By:
- Publication type:
- Article
Immunotherapy May Improve Tumor Sensitivity to Palliative Chemotherapy in Platinum Resistant Ovarian Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e478, doi. 10.1093/oncolo/oyad079
- By:
- Publication type:
- Article
Efficacy of T-Cell Receptor-Based Adoptive Cell Therapy in Cutaneous Melanoma: A Meta-Analysis.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e406, doi. 10.1093/oncolo/oyad078
- By:
- Publication type:
- Article
A Belgian Population-Based Study Reveals Subgroups of Right-sided Colorectal Cancer with a Better Prognosis Compared to Left-sided Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e331, doi. 10.1093/oncolo/oyad074
- By:
- Publication type:
- Article
Retrospective Analysis With Propensity Score Matching of Peripheral T-Cell Lymphoma Treated Frontline With Brentuximab Vedotin and Chemotherapy.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 520, doi. 10.1093/oncolo/oyad068
- By:
- Publication type:
- Article
Acupuncture May Help to Prevent Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Sham-Controlled, Single-Blind Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e436, doi. 10.1093/oncolo/oyad065
- By:
- Publication type:
- Article
Survival Analysis of 1140 Patients with Biliary Cancer and Benefit from Concurrent Renin-Angiotensin Antagonists, Statins, or Aspirin with Systemic Therapy.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 531, doi. 10.1093/oncolo/oyad063
- By:
- Publication type:
- Article
Arterial and Venous Thromboembolism in ALK-Rearrangement-Positive Non-small Cell Lung Cancer: A Population-Based Cohort Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e391, doi. 10.1093/oncolo/oyad061
- By:
- Publication type:
- Article
Prescribing Characteristics of Octreotide Immediate-Release and Long-Acting Release in Patients with Neuroendocrine Tumors.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 479, doi. 10.1093/oncolo/oyad057
- By:
- Publication type:
- Article
Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 465, doi. 10.1093/oncolo/oyad055
- By:
- Publication type:
- Article
Feasibility of Point-of-Care Genomic Profiling in the Diagnosis and Treatment of Cancer of Unknown Primary.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 474, doi. 10.1093/oncolo/oyad054
- By:
- Publication type:
- Article
External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e341, doi. 10.1093/oncolo/oyad050
- By:
- Publication type:
- Article
Correction to: Managing Ibrutinib-Intolerant Patients With B-Cell Malignancies.
- Published in:
- 2023
- Publication type:
- Correction Notice
Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 486, doi. 10.1093/oncolo/oyad044
- By:
- Publication type:
- Article
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 553, doi. 10.1093/oncolo/oyad022
- By:
- Publication type:
- Article
Pathways and Referral of Patients with Cancer in Rural Ethiopia: A Multi-center Retrospective Cohort Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e359, doi. 10.1093/oncolo/oyad032
- By:
- Publication type:
- Article
Cancer Demographics and Time-to-Care in Belize.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e350, doi. 10.1093/oncolo/oyad030
- By:
- Publication type:
- Article
Patients' Perceptions Regarding the Relevance of Items Contained in the Functional Assessment of Cancer Therapy Kidney Symptom Index-19.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 494, doi. 10.1093/oncolo/oyad028
- By:
- Publication type:
- Article
Physical Function and Physical Activity in Older Breast Cancer Survivors: 5-Year Follow-Up from the Climb Every Mountain Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e317, doi. 10.1093/oncolo/oyad027
- By:
- Publication type:
- Article
Actionable Genomic Alterations in Prostate Cancer Among Black and White United States Veterans.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e473, doi. 10.1093/oncolo/oyad042
- By:
- Publication type:
- Article
Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e324, doi. 10.1093/oncolo/oyad020
- By:
- Publication type:
- Article
Patient Engagement With Early Stage Advance Care Planning at a Comprehensive Cancer Center.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 542, doi. 10.1093/oncolo/oyad015
- By:
- Publication type:
- Article
Ramucirumab Plus Docetaxel for Patients with Non-small cell Lung Cancer with Brain Metastases: A Multicenter, Open-Label Single-Arm Phase II Trial.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 551, doi. 10.1093/oncolo/oyad013
- By:
- Publication type:
- Article
Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e425, doi. 10.1093/oncolo/oyad011
- By:
- Publication type:
- Article
Analysis of Female Participant Representation in Registered Oncology Clinical Trials in the United States from 2008 to 2020.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 510, doi. 10.1093/oncolo/oyad009
- By:
- Publication type:
- Article
Safety of Immune Checkpoint Inhibitors in Patients With Advanced Chronic Kidney Disease: A Retrospective Cohort Study.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. e379, doi. 10.1093/oncolo/oyad001
- By:
- Publication type:
- Article
Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 501, doi. 10.1093/oncolo/oyac269
- By:
- Publication type:
- Article